Whittier Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Whittier Trust's NBIX Position: Q3 2026 in Review
Whittier Trust held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 53 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1195.
Whittier Trust first reported a position in NBIX in Q3 2019 and has held it in 29 quarters since. The position peaked at $25K in Q4 2021. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Whittier Trust held 53 shares of Neurocrine Biosciences worth $7.55K as of Q3 2026.
- Whittier Trust left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of Whittier Trust's portfolio in Q3 2026, its #1195 holding.
- Whittier Trust first reported a position in Neurocrine Biosciences in Q3 2019 and has held it in 29 quarters since.
- Whittier Trust's Neurocrine Biosciences position peaked at $25K in Q4 2021.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Whittier Trust's 13F filing for Q3 2026, filed 12 Nov 2026.